Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 1150 of 2529 entries
View as:

Study of the Safety and Efficacy of LCZ696 on Arterial Stiffness in Elderly Patients With Hypertension

Phase: N/A Priority: Normal
NCT ID: NCT01692301 Org: User:
Start: 12/31/12 End: 04/30/15 Due: 04/30/16

Role of Sacubitril/Valsartan in Improving Provider Performance in Managing Heart Failure Under Medicare Alternative Payment Models

Phase: N/A Priority: Normal
NCT ID: NCT05096039 Org: User:
Start: 04/10/20 End: 09/30/20 Due: 09/30/21

Study to Evaluate Treatment of Dabrafenib Plus Trametinib in Subjects With BRAF Mutation-Positive Melanoma That Has Metastasized to the Brain

Phase: N/A Priority: Normal
NCT ID: NCT02039947 Org: User:
Start: 02/21/14 End: 02/14/18 Due: 02/14/19

4EVER - Efficacy, Safety, Health Economics, Translational Research of Postmenopausal Women With Estrogen Receptor Positive Locally Advanced or Metastatic Breast Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01626222 Org: User:
Start: 06/30/12 End: 11/30/13 Due: 11/30/14

Famciclovir Pediatric Formulation in Children 1 to 12 Years of Age With Herpes Simplex Infection

Phase: N/A Priority: Normal
NCT ID: NCT00098059 Org: User:
Start: 02/28/05 End: 12/31/07 Due: 12/31/08

The Effect of QVA149 on Patient Reported Dyspnea in Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD)

Phase: N/A Priority: Normal
NCT ID: NCT01490125 Org: User:
Start: 10/31/11 End: 08/31/12 Due: 08/31/13

Study of Diagnostic Performance of [18F]CTT1057 in BCR

Phase: N/A Priority: Normal
NCT ID: NCT04838613 Org: User:
Start: 09/30/21 End: 11/23/23 Due: 11/23/24

Study of Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of VAY736 in Patients With Idiopathic Pulmonary Fibrosis

Phase: N/A Priority: Normal
NCT ID: NCT03287414 Org: User:
Start: 12/20/17 End: 02/14/22 Due: 02/14/23

Study of Efficacy, Safety and Tolerability of CMK389 in Patients With Chronic Pulmonary Sarcoidosis

Phase: N/A Priority: Normal
NCT ID: NCT04064242 Org: User:
Start: 09/23/20 End: 12/12/23 Due: 12/12/24

Study of Safety of CSJ117 in Participants With Moderate to Severe Uncontrolled Asthma

Phase: N/A Priority: Normal
NCT ID: NCT04946318 Org: User:
Start: 09/08/21 End: 09/08/22 Due: 09/08/23

A Study to Evaluate the Efficacy and Safety of QVM149 (Indacaterol Acetate / Glycopyrronium Bromide / Mometasone Furoate) Versus Salmeterol Xinafoate/Fluticasone Propionate in Children From 12 Years to Less Than 18 Years of Age With Asthma.

Phase: N/A Priority: Normal
NCT ID: NCT05776927 Org: User:
Start: 02/01/26 End: 02/01/29 Due: 02/01/30

Efficacy, Safety and Tolerability of ACZ885 in Pediatric Patients With the Following Cryopyrin-associated Periodic Syndromes: Familial Cold Autoinflammatory Syndrome, Muckle-Wells Syndrome, or Neonatal Onset Multisystem Inflammatory Disease

Phase: N/A Priority: Normal
NCT ID: NCT01576367 Org: User:
Start: 01/16/12 End: 10/13/15 Due: 10/13/16

Safety, Tolerability, and Efficacy Study of LFX453 in Actinic Keratosis Patients

Phase: N/A Priority: Normal
NCT ID: NCT02404389 Org: User:
Start: 03/05/15 End: 01/27/16 Due: 01/27/17

Drug Use Investigation for ARRANON G (Nelarabine) Injection 250mg

Phase: N/A Priority: Normal
NCT ID: NCT01376115 Org: User:
Start: 01/18/08 End: 10/24/17 Due: 10/24/18

Head to Head Study of Anti-VEGF Treatment.

Phase: N/A Priority: Normal
NCT ID: NCT02577107 Org: User:
Start: 01/13/16 End: 07/09/16 Due: 07/09/17

A Multi-part, Double Blind Study to Assess Safety, Tolerability and Efficacy of Tropifexor (LJN452) in PBC Patients

Phase: N/A Priority: Normal
NCT ID: NCT02516605 Org: User:
Start: 09/09/15 End: 08/02/18 Due: 08/02/19

Pharmacokinetics Study of TNO155 in Participants With Mild, Moderate, or Severe Renal Impairment Compared to Matched Healthy Participants

Phase: N/A Priority: Normal
NCT ID: NCT05541159 Org: User:
Start: 03/19/25 End: 07/15/25 Due: 07/15/26

Study to Evaluate Zoledronic Acid on Quality of Life and Skeletal-related Events as Adjuvant Treatment in Patients With Hormone-naïve Prostate Cancer and Bone Metastasis Who Have Undergone Orchiectomy

Phase: N/A Priority: Normal
NCT ID: NCT00237146 Org: User:
Start: 11/30/03 End: 03/31/08 Due: 03/31/09

Treatment of Von Hippel-Lindau (VHL)-Related Hemangioblastoma With PTK787/ZK 222584

Phase: N/A Priority: Normal
NCT ID: NCT00052013 Org: User:
Start: 02/28/03 End: - Due: -

A Phase I Study of LJM716 in Squamous Cell Carcinoma of Head and Neck, or HER2+ Breast Cancer or Gastric Cancer

Phase: N/A Priority: Normal
NCT ID: NCT01598077 Org: User:
Start: 07/31/12 End: 03/31/14 Due: 03/31/15

Injection Intervals in Real-world Neovascular Age-related Macular Degeneration (nAMD) Patients Switching to Brolucizumab With at Least 12 Months of Follow-up

Phase: N/A Priority: Normal
NCT ID: NCT06178770 Org: User:
Start: 12/01/21 End: 12/12/22 Due: 12/12/23

Efficacy and Safety Comparison of RAD001 Versus Sunitinib in the First-line and Second-line Treatment of Patients With Metastatic Renal Cell Carcinoma

Phase: N/A Priority: Normal
NCT ID: NCT00903175 Org: User:
Start: 10/31/09 End: 05/31/15 Due: 05/31/16

Efficacy and Tolerability of BAF312 in Patients With Polymyositis and Dermatomyositis

Phase: N/A Priority: Normal
NCT ID: NCT01148810 Org: User:
Start: 06/15/10 End: 06/13/12 Due: 06/13/13

Ext. Long-term Safety Study in CF Patients: Single Arm TIP

Phase: N/A Priority: Normal
NCT ID: NCT01775137 Org: User:
Start: 02/28/13 End: 11/30/14 Due: 11/30/15

Imatinib Mesylate in Patients With Various Types of Malignancies Involving Activated Tyrosine Kinase Enzymes

Phase: N/A Priority: Normal
NCT ID: NCT00171912 Org: User:
Start: 09/30/04 End: 01/31/12 Due: 01/31/13